Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00162708 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Very Intense Radiotherapy-chemotherapy Regimen in Advanced HNSCC

StatusCompleted
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    Study Identification, Study Status, Sponsor/Collaborators, Oversight, References

    v2

  2. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Altered fractionated radiotherapy and concomitant radio-chemotherapy have been shown to be two possibilities for improving efficacy of radiotherapy in locally advanced head and neck carcinomas. In this multicentric study, we tested the hypothesis that accelerated radiotherapy could be delivered concomitantly with conventional high doses of CDDP-5FU, aiming to improve both local control and on distant metastases as compared to very accelerated radiotherapy.
Trial Details
NCT Number NCT00162708
Lead Sponsor Gustave Roussy, Cancer Campus, Grand Paris
Conditions Oropharynx Cancer, Oral Cancer, Hypopharynx Cancer, Larynx Cancer
Enrollment 120 participants
Start Date
Updated on ClinicalTrials.gov